Viral evasion and subversion of pattern-recognition receptor signalling

The expression of pattern-recognition receptors (PRRs) by immune and tissue cells provides the host with the ability to detect and respond to infection by viruses and other microorganisms. Significant progress has been made from studying this area, including the identification of PRRs, such as Toll-like receptors and RIG-I-like receptors, and the description of the molecular basis of their signalling pathways, which lead to the production of interferons and other cytokines. In parallel, common mechanisms used by viruses to evade PRR-mediated responses or to actively subvert these pathways for their own benefit are emerging. Accumulating evidence on how viral infection and PRR signalling pathways intersect is providing further insights into the function of the pathways involved, their constituent proteins and ways in which they could be manipulated therapeutically.

[1]  J. Tratschin,et al.  Classical Swine Fever Virus Npro Interacts with Interferon Regulatory Factor 3 and Induces Its Proteasomal Degradation , 2007, Journal of Virology.

[2]  Lena Alexopoulou,et al.  Detrimental Contribution of the Toll-Like Receptor (TLR)3 to Influenza A Virus–Induced Acute Pneumonia , 2006, PLoS pathogens.

[3]  A. Bowie,et al.  Poxvirus Protein N1L Targets the I-κB Kinase Complex, Inhibits Signaling to NF-κB by the Tumor Necrosis Factor Superfamily of Receptors, and Inhibits NF-κB and IRF3 Signaling by Toll-like Receptors* , 2004, Journal of Biological Chemistry.

[4]  M. Gale,et al.  Functional and Therapeutic Analysis of Hepatitis C Virus NS3·4A Protease Control of Antiviral Immune Defense* , 2007, Journal of Biological Chemistry.

[5]  K. Ishii,et al.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.

[6]  Ruchi M. Newman,et al.  Identification and Characterization of a Novel Bacterial Virulence Factor That Shares Homology with Mammalian Toll/Interleukin-1 Receptor Family Proteins , 2022 .

[7]  K. Jeang,et al.  Requirement of DDX3 DEAD Box RNA Helicase for HIV-1 Rev-RRE Export Function , 2004, Cell.

[8]  D. Levy,et al.  Inhibition of Interferon Regulatory Factor 7 (IRF7)-Mediated Interferon Signal Transduction by the Kaposi's Sarcoma-Associated Herpesvirus Viral IRF Homolog vIRF3 , 2007, Journal of Virology.

[9]  A. Bauch,et al.  The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response , 2008, The EMBO journal.

[10]  S. Akira,et al.  Lymphocytoid Choriomeningitis Virus Activates Plasmacytoid Dendritic Cells and Induces a Cytotoxic T-Cell Response via MyD88 , 2007, Journal of Virology.

[11]  C. Horvath,et al.  Select Paramyxoviral V Proteins Inhibit IRF3 Activation by Acting as Alternative Substrates for Inhibitor of κB Kinase ϵ (IKKe)/TBK1* , 2008, Journal of Biological Chemistry.

[12]  N. Kato,et al.  DDX3 DEAD-Box RNA Helicase Is Required for Hepatitis C Virus RNA Replication , 2007, Journal of Virology.

[13]  Stanley M Lemon,et al.  Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Akira,et al.  Toll-like receptor–independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation , 2005, The Journal of experimental medicine.

[15]  T. Pollin,et al.  Association of TLR4 Polymorphisms with Symptomatic Respiratory Syncytial Virus Infection in High-Risk Infants and Young Children1 , 2007, The Journal of Immunology.

[16]  F. Weber,et al.  Double-Stranded RNA Is Produced by Positive-Strand RNA Viruses and DNA Viruses but Not in Detectable Amounts by Negative-Strand RNA Viruses , 2006, Journal of Virology.

[17]  K. Knobeloch,et al.  ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation. , 2006, Cellular and molecular biology.

[18]  H. W. Chang,et al.  The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Smahi,et al.  TLR3 Deficiency in Patients with Herpes Simplex Encephalitis , 2007, Science.

[20]  A. Bowie,et al.  Innate immune signaling pathways: lessons from vaccinia virus , 2008 .

[21]  Ralf Bartenschlager,et al.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.

[22]  R. Krug,et al.  A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription , 1981, Cell.

[23]  E. Fikrig,et al.  Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis , 2004, Nature Medicine.

[24]  E. Wimmer,et al.  A protein covalently linked to poliovirus genome RNA. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Bryan R. G. Williams,et al.  Interferon-inducible antiviral effectors , 2008, Nature Reviews Immunology.

[26]  V. Ambros,et al.  Covalent linkage of a protein to a defined nucleotide sequence at the 5'-terminus of virion and replicative intermediate RNAs of poliovirus. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Janeway Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.

[28]  A. Bowie,et al.  A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Arnold Martin,et al.  Processing of Genome 5′ Termini as a Strategy of Negative-Strand RNA Viruses to Avoid RIG-I-Dependent Interferon Induction , 2008, PloS one.

[30]  Hideo Negishi,et al.  Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules , 2008, Proceedings of the National Academy of Sciences.

[31]  M. Hibberd,et al.  Whole-Genome Expression Profiling Reveals That Inhibition of Host Innate Immune Response Pathways by Ebola Virus Can Be Reversed by a Single Amino Acid Change in the VP35 Protein , 2008, Journal of Virology.

[32]  L. Flamand,et al.  Binding of Kaposi's Sarcoma-Associated Herpesvirus K-bZIP to Interferon-Responsive Factor 3 Elements Modulates Antiviral Gene Expression , 2007, Journal of Virology.

[33]  Jie-Oh Lee,et al.  Structures of TLR-ligand complexes. , 2008, Current opinion in immunology.

[34]  I. Haga,et al.  Vaccinia virus protein A46R targets multiple Toll-like–interleukin-1 receptor adaptors and contributes to virulence , 2005, The Journal of experimental medicine.

[35]  J. Schoggins,et al.  Sensing Infection by Adenovirus: Toll-Like Receptor-Independent Viral DNA Recognition Signals Activation of the Interferon Regulatory Factor 3 Master Regulator , 2007, Journal of Virology.

[36]  B. Berkhout,et al.  The Ebola Virus VP35 Protein Is a Suppressor of RNA Silencing , 2007, PLoS pathogens.

[37]  S. Cooray,et al.  Inhibition of IκB Kinase by Vaccinia Virus Virulence Factor B14 , 2008, PLoS pathogens.

[38]  D. Greaves,et al.  Mechanism of Inactivation of NF-κB by a Viral Homologue of IκBα , 2000, The Journal of Biological Chemistry.

[39]  A. Bowie,et al.  The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling , 2007, Nature Reviews Immunology.

[40]  J. Hiscott,et al.  Manipulation of the nuclear factor-κB pathway and the innate immune response by viruses , 2006, Oncogene.

[41]  W. Haining,et al.  Resolution of a chronic viral infection after interleukin-10 receptor blockade , 2006, The Journal of experimental medicine.

[42]  Osamu Takeuchi,et al.  Sequential control of Toll-like receptor–dependent responses by IRAK1 and IRAK2 , 2008, Nature Immunology.

[43]  K. Honda,et al.  DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response , 2007, Nature.

[44]  L. Mazzacurati,et al.  Kaposi's Sarcoma-associated Herpesvirus (KSHV) Oncoprotein K13 Bypasses TRAFs and Directly Interacts with the IκB Kinase Complex to Selectively Activate NF-κB without JNK Activation* , 2007, Journal of Biological Chemistry.

[45]  M. Fresno,et al.  African Swine Fever Virus IAP-Like Protein Induces the Activation of Nuclear Factor Kappa B , 2002, Journal of Virology.

[46]  A. Bowie,et al.  The human adaptor SARM negatively regulates adaptor protein TRIF–dependent Toll-like receptor signaling , 2006, Nature Immunology.

[47]  Richard A Flavell,et al.  Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[48]  William M. Lee,et al.  Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[49]  I. Haga,et al.  Evasion of innate immunity by vaccinia virus , 2005, Parasitology.

[50]  R. Medzhitov,et al.  Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. , 2006, Immunity.

[51]  H. Ezelle,et al.  HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. , 2008, Virology.

[52]  George Kollias,et al.  Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses , 2008, Nature Immunology.

[53]  A. Bowie,et al.  TLR3 in antiviral immunity: key player or bystander? , 2005, Trends in immunology.

[54]  Shizuo Akira,et al.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.

[55]  Brooke A. Jude,et al.  Subversion of the innate immune system by a retrovirus , 2003, Nature Immunology.

[56]  Qiang Sun,et al.  Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKε Molecular Complex from the Mitochondrial Outer Membrane by Hepatitis C Virus NS3-4A Proteolytic Cleavage , 2006, Journal of Virology.

[57]  J. Curtis,et al.  TLR3 Increases Disease Morbidity and Mortality from Vaccinia Infection1 , 2008, The Journal of Immunology.

[58]  S. Akira,et al.  Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid–inducible gene-I and melanoma differentiation–associated gene 5 , 2008, The Journal of experimental medicine.

[59]  R. Flavell,et al.  TLR 3 Deletion Limits Mortality and Disease Severity due to Phlebovirus Infection 1 , 2006 .

[60]  Osamu Takeuchi,et al.  Genetic analysis of resistance to viral infection , 2007, Nature Reviews Immunology.

[61]  S. Buch,et al.  The HTLV-I p30 Interferes with TLR4 Signaling and Modulates the Release of Pro- and Anti-inflammatory Cytokines from Human Macrophages* , 2006, Journal of Biological Chemistry.

[62]  D M Crothers,et al.  Fragments of the HIV-1 Tat protein specifically bind TAR RNA. , 1990, Science.

[63]  Yuqiong Liang,et al.  Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor , 2007, Proceedings of the National Academy of Sciences.

[64]  P. Fisher,et al.  MDA-5 Is Cleaved in Poliovirus-Infected Cells , 2007, Journal of Virology.

[65]  Zhijian J. Chen,et al.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. , 2005, Cell.

[66]  Michael Gale,et al.  Inhibition of Retinoic Acid-Inducible Gene I-Mediated Induction of Beta Interferon by the NS1 Protein of Influenza A Virus , 2006, Journal of Virology.

[67]  R. Fukuda,et al.  Binding of influenza A virus NS1 protein to dsRNA in vitro. , 1992, The Journal of general virology.

[68]  Michael Gale,et al.  Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA , 2008, Nature.

[69]  M. Katze,et al.  Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. , 1997, Virology.

[70]  Zheng‐gang Liu,et al.  The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors , 2008, Nature Immunology.

[71]  Gunther Hartmann,et al.  5'-Triphosphate RNA Is the Ligand for RIG-I , 2006, Science.

[72]  N. Kato,et al.  Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses , 2005, Hepatology.

[73]  Zhijian J. Chen,et al.  Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3 , 2005, Cell.

[74]  R. Kobayashi,et al.  The Tat Protein of Human Immunodeficiency Virus Type 1 Is a Substrate and Inhibitor of the Interferon-induced, Virally Activated Protein Kinase, PKR* , 1997, The Journal of Biological Chemistry.

[75]  Zhongbin Chen,et al.  Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome Coronavirus , 2007, Journal of Biological Chemistry.

[76]  K. Tyler,et al.  Does Toll-like receptor 3 play a biological role in virus infections? , 2004, Virology.

[77]  E. Mackow,et al.  The NY-1 Hantavirus Gn Cytoplasmic Tail Coprecipitates TRAF3 and Inhibits Cellular Interferon Responses by Disrupting TBK1-TRAF3 Complex Formation , 2008, Journal of Virology.

[78]  A. Bowie,et al.  A 46 R and A 52 R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling , 2000 .

[79]  R. Flavell,et al.  TLR3 Deletion Limits Mortality and Disease Severity due to Phlebovirus Infection1 , 2006, The Journal of Immunology.

[80]  C. Coban,et al.  TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines , 2008, Nature.

[81]  Takashi Taguchi,et al.  Hepatitis C virus NS5A protein interacts with 2',5'-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner. , 2004, The Journal of general virology.

[82]  N. Sullivan,et al.  Immunopathology of highly virulent pathogens: insights from Ebola virus , 2007, Nature Immunology.

[83]  S. Goodbourn,et al.  The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[84]  Shizuo Akira,et al.  Shared and Unique Functions of the DExD/H-Box Helicases RIG-I, MDA5, and LGP2 in Antiviral Innate Immunity1 , 2005, The Journal of Immunology.

[85]  Mark Harris,et al.  Hepatitis C virus NS5A: tales of a promiscuous protein. , 2004, The Journal of general virology.

[86]  Osamu Takeuchi,et al.  MDA5/RIG-I and virus recognition. , 2008, Current opinion in immunology.

[87]  A. Pichlmair,et al.  RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates , 2006, Science.

[88]  Osamu Takeuchi,et al.  IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction , 2005, Nature Immunology.

[89]  J. Tschopp,et al.  TRADD protein is an essential component of the RIG-like helicase antiviral pathway. , 2008, Immunity.

[90]  M. Katze,et al.  Inhibition of Double-Stranded RNA-Dependent Protein Kinase PKR by Vaccinia Virus E3: Role of Complex Formation and the E3 N-Terminal Domain , 1998, Molecular and Cellular Biology.

[91]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[92]  Erica Ollmann Saphire,et al.  Ebola Virus VP35 Protein Binds Double-Stranded RNA and Inhibits Alpha/Beta Interferon Production Induced by RIG-I Signaling , 2006, Journal of Virology.

[93]  T. Wolff,et al.  Viral targeting of the interferon-β-inducing Traf family member-associated NF-κB activator (TANK)-binding kinase-1 , 2005 .

[94]  Clinton Jones,et al.  The Infected Cell Protein 0 Encoded by Bovine Herpesvirus 1 (bICP0) Induces Degradation of Interferon Response Factor 3 and, Consequently, Inhibits Beta Interferon Promoter Activity , 2007, Journal of Virology.

[95]  P. Schaffer,et al.  Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: Potential role in blocking IFN-beta induction. , 2007, Virology.

[96]  S. Akira,et al.  Hepatitis C Virus Nonstructural Protein 5A Modulates the Toll-Like Receptor-MyD88-Dependent Signaling Pathway in Macrophage Cell Lines , 2007, Journal of Virology.

[97]  K. Conzelmann,et al.  The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I. , 2008, Molecular cell.

[98]  L. Teyton,et al.  Interleukin-10 determines viral clearance or persistence in vivo , 2006, Nature Medicine.

[99]  A. Wieser,et al.  Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain–containing proteins , 2008, Nature Medicine.

[100]  P. D. de Sessions,et al.  West Nile Virus Nonstructural Protein 1 Inhibits TLR3 Signal Transduction , 2008, Journal of Virology.

[101]  E. Mackow,et al.  The NY1 Hantavirus Gn Cytoplasmic Tail Coprecipitates TRAF 3 and Inhibits Cellular Interferon Responses by Disrupting TBK 1-TRAF 3 Complex Formation , 2008 .

[102]  A. Bowie,et al.  Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKε‐mediated IRF activation , 2008, The EMBO journal.

[103]  Z. Zhai,et al.  VISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling , 2005 .

[104]  C. Janeway,et al.  Viral interference with IL-1 and toll signaling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[105]  A. Bowie,et al.  Vaccinia Virus Protein A52R Activates p38 Mitogen-activated Protein Kinase and Potentiates Lipopolysaccharide-induced Interleukin-10* , 2005, Journal of Biological Chemistry.

[106]  A. Bowie,et al.  IRAK-2 Participates in Multiple Toll-like Receptor Signaling Pathways to NFκB via Activation of TRAF6 Ubiquitination* , 2007, Journal of Biological Chemistry.

[107]  Rudi Beyaert,et al.  Sensing of Viral Infection and Activation of Innate Immunity by Toll-Like Receptor 3 , 2008, Clinical Microbiology Reviews.

[108]  S. Finke,et al.  Identification of the Rabies Virus Alpha/Beta Interferon Antagonist: Phosphoprotein P Interferes with Phosphorylation of Interferon Regulatory Factor 3 , 2005, Journal of Virology.

[109]  S. Akira,et al.  Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. , 2004, Blood.

[110]  L. O’Neill When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. , 2008, Immunity.

[111]  K. Knobeloch,et al.  Vaccinia Virus E3 Protein Prevents the Antiviral Action of ISG15 , 2008, PLoS pathogens.

[112]  C. Coban,et al.  A Toll-like receptor–independent antiviral response induced by double-stranded B-form DNA , 2006, Nature Immunology.

[113]  N. Reich,et al.  The Pathogenic NY-1 Hantavirus G1 Cytoplasmic Tail Inhibits RIG-I- and TBK-1-Directed Interferon Responses , 2006, Journal of Virology.

[114]  A. Bowie Translational Mini‐Review Series on Toll‐like Receptors:
Recent advances in understanding the role of Toll‐like receptors in anti‐viral immunity , 2007, Clinical and experimental immunology.

[115]  G. Barber,et al.  STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling , 2008, Nature.

[116]  Douglas T. Golenbock,et al.  Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus , 2000, Nature Immunology.

[117]  J. Casanova,et al.  Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases , 2007, Nature Immunology.

[118]  I. Haga,et al.  The Poxvirus Protein A52R Targets Toll-like Receptor Signaling Complexes to Suppress Host Defense , 2003, The Journal of experimental medicine.

[119]  J. Hiscott,et al.  HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators , 2001, Oncogene.

[120]  S. Akira,et al.  Toll-like Receptor 9–mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells , 2003, The Journal of experimental medicine.

[121]  M. Barro,et al.  Rotavirus NSP1 Inhibits Expression of Type I Interferon by Antagonizing the Function of Interferon Regulatory Factors IRF3, IRF5, and IRF7 , 2007, Journal of Virology.